The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®3, Zubsolv®4, Bunavail™5, Probuphine®6) is an opioid medication used to treat opioid addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed for take-home use, by prescription.1 This, in addition to the pharmacological and safety profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Help your website visitors find a certified physician by adding
 a button to your website

NAABT invites you to link to our Patient Physician Matching System. This convenient shortcut button can easily be added to your existing website. It provides a simple way for your visitors to connect with a physician that offers buprenorphine treatment without the need to navigate through our entire site. Choose from the buttons below for the one that best fits your website design. We would appreciate it very much if you would email us once the banner is on your site. Thank you! MakeContact@naabt.org

Forward this page to your webmaster or add the text to your html code, and the button will appear. For direct links the page address is: http://www.naabt.org/patient_doctor/splash.cfm

468x60 banner
<a href="http://www.naabt.org/redirect/ppms.cfm"><img border="0" src=" http://www.naabt.org/images/banners/ppms-468x60.jpg" alt="NAABT Patient/Physician Matching System Banner " width="468" height="60"></a>

petition banner 180x150
<a href="http://www.naabt.org/redirect/ppms.cfm"><img border="0" src=" http://www.naabt.org/images/banners/ppms-180x150.jpg" alt="NAABT Patient/Physician Matching System Banner" width="180" height="150"></a>

petition banner 119x45
<a href="http://www.naabt.org/redirect/ppms.cfm"><img border="0" src=" http://www.naabt.org/images/banners/ppms-119x45.jpg" alt="NAABT Patient/Physician Matching System Banner" width="119" height="45"></a>

petition banner 120x90
<a href="http://www.naabt.org/redirect/ppms.cfm"><img border="0" src=" http://www.naabt.org/images/banners/ppms-120x90.jpg" alt="NAABT Patient/Physician Matching System Banner" width="120" height="90"></a>


<a href="http://www.naabt.org/redirect/ppms.cfm"><img border="0" src=" http://www.naabt.org/images/banners/ppms-120x600.jpg" alt="NAABT Patient/Physician Matching System Banner" width="120" height="600"></a>

National Alliance of Advocates for Buprenorphine Treatment (NAABT)
PO Box 333, Farmington CT 06034, Fax. 860.269.4391, www.naabt.org email address: MakeContact@naabt.org

This page was last modified on : 10/29/2013

The Purpose of Buprenorphine Treatment:

To suppress the debilitating symptoms of cravings and withdrawal, enabling the patient to engage in therapy, counseling and support, so they can implement positive long-term changes in their lives which develops into the new healthy patterns of behavior necessary to achieve sustained addiction remission. - explain -

The National Alliance of Advocates for Buprenorphine Treatment is a non-profit organization charged with the mission to:

  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.
  3. Subutex Discontinued in the US market in late 2011.
  4. Zubsolv (bup/nx sublingual tablet) FDA approved 7/3/2013 see buprenorphine pipeline graphic -in pharmacies now.
  5. Bunavail (bup/nx bucal film) FDA approved 6/6/2014 see buprenorphine pipeline graphic -in pharmacies now.
  6. Probuphine FDA approved 5/26/2016 - FDA Probuphine press release